APA

Miller P. D., Pannacciulli N., Wagman R. B. & Cummings S. R. (20180507). Response to the Letter: Bone Turnover as a Potential Determinant of Bone Mineral Density Increase Following the Transition From Bisphosphonates to Either Denosumab or Zoledronic Acid. : The Journal of clinical endocrinology and metabolism.

Chicago

Miller Paul D, Pannacciulli Nico, Wagman Rachel B and Cummings Steven R. 20180507. Response to the Letter: Bone Turnover as a Potential Determinant of Bone Mineral Density Increase Following the Transition From Bisphosphonates to Either Denosumab or Zoledronic Acid. : The Journal of clinical endocrinology and metabolism.

Harvard

Miller P. D., Pannacciulli N., Wagman R. B. and Cummings S. R. (20180507). Response to the Letter: Bone Turnover as a Potential Determinant of Bone Mineral Density Increase Following the Transition From Bisphosphonates to Either Denosumab or Zoledronic Acid. : The Journal of clinical endocrinology and metabolism.

MLA

Miller Paul D, Pannacciulli Nico, Wagman Rachel B and Cummings Steven R. Response to the Letter: Bone Turnover as a Potential Determinant of Bone Mineral Density Increase Following the Transition From Bisphosphonates to Either Denosumab or Zoledronic Acid. : The Journal of clinical endocrinology and metabolism. 20180507.